CYTOKINE RECEPTOR TARGETED MOLECULES FOR TREATMENT OF MEOPLASTIC CELL GROWTH - Patent 0584251

(19)

(11)

EP 0 584 251 A1

(12)

(43)	Date of publication:
	02.03.1994 Bulletin 1994/09

(21)	Application number: 92912726.0

(22)	Date of filing: 15.05.1992

(51)

International Patent Classification (IPC):

A61K 38/ 00^{( . )}
A61K 47/ 48^{( . )}
C07K 14/ 245^{( . )}
C07K 14/ 54^{( . )}
C07K 19/ 00^{( . )}

A61K 39/ 395^{( . )}
A61P 35/ 00^{( . )}
C07K 14/ 34^{( . )}
C07K 14/ 55^{( . )}

(86)	International application number:
	PCT/US1992/004093

(87)	International publication number:
	WO 1992/020364 (26.11.1992 Gazette 1992/29)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

(30)

Priority:

17.05.1991 US 19910701932

(71)	Applicant: SERAGEN, INC.
	Hopkinton, MA 01748 (US)

(72)	Inventors:
	WATERS, Cory, Ann Bedford, MA 01730 (US) POISSON, Louis, R. Manville, RI 02838 (US)

(74)	Representative: Roberts, Alison Christine, et al
	Kilburn & Strode, 30 John Street London WC1N 2DD London WC1N 2DD (GB)

(54)	CYTOKINE RECEPTOR TARGETED MOLECULES FOR TREATMENT OF MEOPLASTIC CELL GROWTH